Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin.

Sato, Ken; Naganuma, Atsushi; Nagashima, Tamon; Hoshino, Takashi; Uehara, Daisuke; Arai, Yousuke; Horiuchi, Katsuhiko; Yuasa, Kazuhisa; Takayama, Hisashi; Arai, Hirotaka; Hatanaka, Takeshi; Ohyama, Tatsuya; Tahara, Hiroki; Sohara, Naondo; Kobayashi, Takeshi; Horiguchi, Norio; Yamazaki, Yuichi; Kakizaki, Satoru; Kusano, Motoyasu; Yamada, Masanobu; Murase, Takayo; Nakamura, Takashi

Sato, Ken; Naganuma, Atsushi; Nagashima, Tamon; Hoshino, Takashi; Uehara, Daisuke; Arai, Yousuke; Horiuchi, Katsuhiko; Yuasa, Kazuhisa; Takayama, Hisashi; Arai, Hirotaka; Hatanaka, Takeshi; Ohyama, Tatsuya; Tahara, Hiroki; Sohara, Naondo; Kobayashi, Takeshi; Horiguchi, Norio; Yamazaki, Yuichi; Kakizaki, Satoru; Kusano, Motoyasu; Yamada, Masanobu; Murase, Takayo; Nakamura, Takashi.

Afiliação

Sato K; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Naganuma A; Department of Hepatology, Heisei Hidaka Clinic, Takasaki, Japan.
Nagashima T; Department of Gastroenterology, Takasaki General Medical Center, National Hospital Organization, Takasaki, Japan.
Hoshino T; Department of Gastroenterology, Shibukawa General Medical Center, National Hospital Organization, Shibukawa, Japan.
Uehara D; Department of Gastroenterology, Takasaki General Medical Center, National Hospital Organization, Takasaki, Japan.
Arai Y; Department of Gastroenterology, Takasaki General Medical Center, National Hospital Organization, Takasaki, Japan.
Horiuchi K; Department of Gastroenterology, Shibukawa General Medical Center, National Hospital Organization, Shibukawa, Japan.
Yuasa K; Department of Gastroenterology, Gunma Chuo Hospital, Maebashi, Japan.
Takayama H; Department of Gastroenterology, Gunma Chuo Hospital, Maebashi, Japan.
Arai H; Department of Gastroenterology, Maebashi Red Cross Hospital, Maebashi, Japan.
Hatanaka T; Department of Gastroenterology, Maebashi Red Cross Hospital, Maebashi, Japan.
Ohyama T; Department of Gastroenterology, Takasaki General Medical Center, National Hospital Organization, Takasaki, Japan.
Tahara H; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Sohara N; Department of Gastroenterology, Gunma Chuo Hospital, Maebashi, Japan.
Kobayashi T; Department of Gastroenterology, Takasaki General Medical Center, National Hospital Organization, Takasaki, Japan.
Horiguchi N; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Yamazaki Y; Department of Hepatology, Heisei Hidaka Clinic, Takasaki, Japan.
Kakizaki S; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Kusano M; Department of Hepatology, Heisei Hidaka Clinic, Takasaki, Japan.
Yamada M; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Murase T; Department of Hepatology, Heisei Hidaka Clinic, Takasaki, Japan.
Nakamura T; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.

Hepatol Res ; 48(3): E347-E353, 2018 Feb.

Article em En | MEDLINE | ID: mdl-28834004

Palavras-chave

chronic hepatitis C; genotype 2; ribavirin; sofosbuvir; uric acid

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Hepatol Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão